Key result
Higher VExUS scores strongly correlate with invasively measured RAP and hepato-renal dysfunction in CICU patients.
Why the study?
The Venous Excess Ultrasound Score provides a noninvasive assessment of systemic venous congestion in AHF and cardiogenic shock, but its physiological correlates in the cardiac intensive care unit remained incompletely characterized.
Does the noninvasive Venous Excess Ultrasound Score (VExUS) correlate with invasively measured right atrial pressure and identify hepato-renal organ dysfunction in patients admitted to the CICU with acute heart failure or cardiogenic shock?
Cohort (n=94)
VExUS operators were not formally blinded to invasive RAP values or other clinical information
No
Does the noninvasive Venous Excess Ultrasound Score (VExUS) correlate with invasively measured right atrial pressure and identify hepato-renal organ dysfunction in patients admitted to the CICU with acute heart failure or cardiogenic shock?
In CICU patients with acute heart failure or cardiogenic shock, VExUS strongly correlates with invasively measured right atrial pressure and identifies a higher burden of hepato-renal biochemical dysfunction beyond RAP alone, supporting its complementary use for congestion phenotyping.
May refine venous congestion assessment in CICU; leaves open whether VExUS improves outcomes over RAP.
Background Venous congestion is a major determinant of organ dysfunction in acute heart failure (AHF) and cardiogenic shock (CS). The Venous Excess Ultrasound Score (VExUS) provides a noninvasive assessment of systemic venous congestion, but its physiological correlates in the cardiac intensive care unit (CICU) remain incompletely characterized. Methods In this prospective single-center study, 94 patients with AHF or CS underwent simultaneous VExUS assessment and invasive right atrial pressure (RAP) measurement within 24 hours of CICU admission. VExUS (graded 0–3; Low 0–1 vs High 2–3) was evaluated for correlation with RAP and associations with hemodynamic, echocardiographic and organ dysfunction indices. Prespecified RAP–VExUS phenotypes (RAP ≤ 10 vs > 10 mmHg; Low vs High VExUS) were used to assess differences in hepato–renal biochemical markers, with adjustment for positive pressure ventilation and SCAI stage. In-hospital mortality was explored using univariate logistic regression. Results High VExUS was present in 29 patients (31%). VExUS correlated with RAP (ρ = 0.67), inversely with the MAP–RAP gradient, and was associated with impaired right ventricular function and higher hepato–renal dysfunction biomarkers, but not with lactate or urine output. RAP–VExUS discordance occurred in 30.9% of patients. Among patients with elevated RAP (> 10 mmHg), those with High VExUS showed greater hepato–renal biochemical dysfunction than those with Low VExUS (p < 0.01). The incremental contribution of VExUS beyond RAP was mainly evident for bilirubin. In-hospital mortality was numerically higher in High versus Low VExUS patients, without reaching statistical significance (24% vs 15%, p = NS). Conclusions In patients with acute heart failure or cardiogenic shock, VExUS was associated with invasively measured RAP and hepato-renal biochemical dysfunction, suggesting a complementary role in congestion phenotyping alongside invasive hemodynamic assessment.
No takes yet. Share an insight, caveat, or question.
Filomia et al. (2026) conducted a cohort in Acute heart failure or cardiogenic shock (n=94). High Venous Excess Ultrasound Score (VExUS grade 2–3) vs. Low Venous Excess Ultrasound Score (VExUS grade 0–1) was evaluated on Correlation and association between VExUS grade (0–3; High 2–3 vs Low 0–1) and simultaneously invasively measured right atrial pressure (RAP, mmHg) (Spearman ρ = 0.67, p=<0.001). The VExUS score strongly correlated with invasively measured right atrial pressure (ρ = 0.67, p < 0.001) and was associated with greater hepato-renal biochemical dysfunction in CICU patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: